Moneycontrol PRO
HomeNewsCipla

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • F&O expiry to keep market volatile; 5 stocks where experts see 8-16% upside

    Experts point out the broader structure of the market continues to remain weak as Nifty is making a lower top and lower bottom formation.

  • Pharma index up 45% from March lows; CLSA says earnings momentum to continue, raises targets

    The Nifty Pharma index gained half a percent on May 7, taking gains to around 45 percent since March 23.

  • Experts say these 7 stocks are a good long-term bet amid virus-led crisis

    There's no relief from the COVID-19 front as the numbers are not showing any signs of slowing down yet and that could result in further extension of the lockdown, said Ajit Mishra of Religare Broking.

  • Nifty has to surpass 9,350 for strong upmove; check out these 5 picks for this week

    It needs to be seen if we can cross the medium-term resistance of 9,350. This would mean a lot for the markets.

  • Hot Stocks | Federal Bank, SBI are 2 short-term buys with 19-20% upside

    Bank Nifty has been a laggard in the current up move and it should witness a strong up move as it has crossed its 20-day short term average after two months.

  • Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

    Mitessh Thakkar of mitesshthakkar.com recommends buying Apollo Hospitals with a stop loss of Rs 1,174, target at Rs 1,235 and CESC with a stop loss of Rs 412, target at Rs 450.

  • Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

    Ashwani Gujral of ashwanigujral.com suggests buying Sun Pharma with a stop loss of Rs 388, target of Rs 404 and Cipla with a stop loss of Rs 420, target of Rs 435.

  • Gujarat Gas, Britannia among 10 stocks which brokerages have upgraded to 'buy'

    Gujarat Gas, Cipla among 10 stocks which brokerages have upgraded to 'buy'

  • Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

    Mitesh Thakkar of miteshthakkar.com recommends buying State Bank of India with a stop loss of Rs 320 and target of Rs 335 and Ambuja Cements with a stop loss of Rs 207.5 and target of Rs 222.

  • With Budget behind us, brokerages cut target price on 5 stocks post Q3 results

    Monetary Policy Committee (MPC) of Reserve Bank of India (RBI) has kept the repo rate under the liquidity adjustment facility (LAF) unchanged at 5.15 percent.

  • Top buy and sell ideas by Ashwani Gujral, Mitesh Thakkar, Prakash Gaba for short term

    Prakash Gaba of prakashgaba.com recommends buying Havells India with target at Rs 645 and stop loss at Rs 623 and IndusInd Bank with target at Rs 1425 and stop loss at Rs 1297.

  • Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

    Ashwani Gujral of ashwanigujral.com recommends buying PVR with a stop loss of Rs 1960, target of Rs 2010 and Kotak Mahindra Bank with a stop loss of Rs 1630, target of Rs 1665.

  • Top buy and sell ideas by Ashwani Gujral, Mitesh Thakkar, Prakash Gaba for short term

    Mitesh Thakkar of miteshthakkar.com recommends buying ACC with a stop loss of Rs 1533 for target of Rs 1580 and Infosys with a stop loss of Rs 775 for target of Rs 806.

  • Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

    Mitesh Thakkar of miteshthakkar.com recommends buying Bharti Airtel with a stop loss of Rs 461 for target of Rs 485 and GAIL India with a stop loss of Rs 125 for target of Rs 137.

  • Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

    Sudarshan Sukhani of s2analytics.com recommends buying Bosch with stop loss at Rs 15030 and target of Rs 15865 and Bharti Infratel with stop loss at Rs 249 and target of Rs 262.

  • Nifty may rally to 12,400 levels if it sustains above 12K; Hindalco among top 3 buy ideas

    Shabbir Kayyumi of Narnolia Financial Advisors said a sustained move above 12,000 will push the index higher towards previous highs, starting around 12,100 and can extend towards 12,400

  • Morgan Stanley bullish on these 2 pharma stocks which could give 32-47% return

    Morgan Stanley also has overweight rating on Lupin with a target price at Rs 1,003, implying 47 percent potential upside from current levels as it believes the share price will rise in absolute terms over the next 30 days.

  • Despite a 1% decline in Nifty Pharma index Deutsche Bank is betting on these 3 stocks

    Deutsche's top picks are Torrent Pharma, Aurobindo Pharma and Cipla which all are buy calls.

  • 'As long as Nifty trades above 11,591, maintain a buy-on-dips strategy'

    Nifty’s 5-week SMA is rising and is placed around 11,611, which implies weakness is only below the crucial support of 11,611

  • Top buy and sell ideas by Sudarshan Sukhani, Mitessh Thakkar for short term

    Sudarshan Sukhani of s2analytics.com recommends buying Kotak Mahindra Bank with stop loss at Rs 1355 and target of Rs 1395 and Infosys with stop loss at Rs 732 and target of Rs 745.

  • Standard Chartered says earnings & election outcome to drive market, bets on these 10 stocks

    The global investment bank is of the view that going forward, the two major events that will give a new direction to the market are Q4FY19 results and the outcome of the central elections.

  • Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

    Mitessh Thakkar of mitesshthakkar.com recommends buying Balkrishna Indistries with a stop loss of Rs 839 and target of Rs 885, Dabur India with a stop loss of Rs 431 and target of Rs 445 and Mahindra & Mahindra with a stop loss of Rs 638 and target of Rs 662.

  • Top buy and sell ideas by Ashwani Gujral, Mitessh Thakkar, Prakash Gaba for short term

    Mitessh Thakkar of mitesshthakkar.com recommends buying CESC with a stop loss of Rs 716 and target of Rs 755, Cipla with a stop loss of Rs 527 and target of Rs 548 and Hindalco Industries with a stop loss of Rs 207 and target of Rs 219.

  • Hindalco, Voltas among short-term trading ideas that can give 3-15% retruns

    Volatility is likely to increase further as we approach Interim Budget, suggest experts and investors should be prepared for sudden movements on either side

  • Buy Cipla above Rs 536, says Shabbir Kayyumi

    The sustainability of RSI above 50 adds the conviction of buying the scrip above Rs 536 for the target of Rs 580 with stop loss of Rs 510 marks.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347